- Home
- CYCN vs SBFM Comparison
CYCN vs SBFM Comparison
Compare CYCN & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCN
- SBFM
- Stock Information
- Founded
- CYCN 2018
- SBFM 2006
- Country
- CYCN United States
- SBFM United States
- Employees
- CYCN N/A
- SBFM N/A
- Industry
- CYCN Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- CYCN Health Care
- SBFM Health Care
- Exchange
- CYCN Nasdaq
- SBFM Nasdaq
- Market Cap
- CYCN 8.0M
- SBFM 6.6M
- IPO Year
- CYCN N/A
- SBFM N/A
- Fundamental
- Price
- CYCN $2.43
- SBFM $1.48
- Analyst Decision
- CYCN
- SBFM Strong Buy
- Analyst Count
- CYCN 0
- SBFM 1
- Target Price
- CYCN N/A
- SBFM $15.00
- AVG Volume (30 Days)
- CYCN 25.2K
- SBFM 44.0K
- Earning Date
- CYCN 11-13-2025
- SBFM 11-04-2025
- Dividend Yield
- CYCN N/A
- SBFM N/A
- EPS Growth
- CYCN N/A
- SBFM N/A
- EPS
- CYCN N/A
- SBFM N/A
- Revenue
- CYCN $2,174,000.00
- SBFM $36,341,741.00
- Revenue This Year
- CYCN N/A
- SBFM $32.20
- Revenue Next Year
- CYCN N/A
- SBFM $32.74
- P/E Ratio
- CYCN N/A
- SBFM N/A
- Revenue Growth
- CYCN N/A
- SBFM 19.22
- 52 Week Low
- CYCN $1.27
- SBFM $1.17
- 52 Week High
- CYCN $9.47
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- CYCN 47.88
- SBFM 53.75
- Support Level
- CYCN $2.13
- SBFM $1.45
- Resistance Level
- CYCN $2.59
- SBFM $1.53
- Average True Range (ATR)
- CYCN 0.20
- SBFM 0.06
- MACD
- CYCN 0.02
- SBFM 0.01
- Stochastic Oscillator
- CYCN 49.18
- SBFM 74.29
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.